Related Experiment Video
Updated: Jul 1, 2025
03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
749
Eosinophilia and wheeze: thinking beyond asthma
Stephanie L Kuek1, Colin Pettman2, Melanie R Neeland3,4
1Respiratory and Sleep Medicine, Royal Children's Hospital, Melbourne, Australia.
Breathe (Sheffield, England)
|March 14, 2024
Summary
Primary idiopathic hypereosinophilic syndrome is a rare disorder causing organ damage. Mepolizumab offers a safe, effective treatment, reducing the need for steroids.
Area of Science:
- Hematology
- Immunology
- Rare Diseases
Background:
- Primary idiopathic hypereosinophilic syndrome (HES) is a rare clonal disorder.
- It is characterized by sustained eosinophilia and potential end-organ damage.
- Current treatments often involve corticosteroids with significant side effects.
Observation:
- Patients with HES experience damage across multiple organ systems.
- Eosinophil proliferation drives the pathology in HES.
- Steroid-dependent treatments carry substantial long-term risks.
Findings:
- Targeted monoclonal antibodies, specifically mepolizumab, demonstrate efficacy in HES.
- Mepolizumab targets interleukin-5 (IL-5), a key cytokine in eosinophil development.
- This targeted therapy provides a steroid-sparing alternative.
Implications:
- Mepolizumab offers a safer and effective treatment option for HES.
- Reduced reliance on corticosteroids can mitigate treatment-related toxicities.
- Targeted therapies represent a significant advancement in managing rare eosinophilic disorders.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:20Asthma: Pathogenesis and Management
396
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
396
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
294
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
294
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K